For more information

on this study please

call +1 877-379-3718

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.

Study ID

APV10018

Study Title A Phase I, Randomized, Open Label, Four Arm, Two Period, Two 2x2, Crossover, Drug Interaction Study to Assess Steady-State Plasma Amprenavir and Atazanavir Pharmacokinetics following Administration of Fosamprenavir 700mg BID + Ritonovir 100mg BID + Atazanavir 300mg QD, Fosamprenavir 700mg BID + ...
Clinicaltrials.gov Identifier
Sponsor GlaxoSmithKline
Collaborators N/A
Study Recruitment Status Completed
Generic Name fosamprenavir
Trade Name Telzer,Telzir,Lexiva
Study Indication Infection, Human Immunodeficiency Virus